Metraipolis › archive › dc_57f82a296ea4

The Use of Statins in Parkinson's and Alzheimer's Disease: A 2021-2025 State-of-the-Art Review of Clinical and Preclinical Evidence — Europe PMC PMID:42252551

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42252551
DOI: 10.1002/prp2.70280
License (as archived): solo-consultazione
Archived: 2026-11-01T01:43:47.456Z
SHA-256 of the archived text: d012e62d0d44c4f2636bfb5942b5e24c66a21f46d98b14c436dcf19309779579
Stable URL of this page: https://metraipolis.com/documento/dc_57f82a296ea4

How to cite

The Use of Statins in Parkinson's and Alzheimer's Disease: A 2021-2025 State-of-the-Art Review of Clinical and Preclinical Evidence — Europe PMC PMID:42252551 — Europe PMC (en), https://europepmc.org/article/MED/42252551 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_57f82a296ea4 (Metraipolis archive dc_57f82a296ea4, sha256 d012e62d0d44c4f2636bfb5942b5e24c66a21f46d98b14c436dcf19309779579)

BibTeX

@misc{dc57f82a296ea4,
  title = {The Use of Statins in Parkinson's and Alzheimer's Disease: A 2021-2025 State-of-the-Art Review of Clinical and Preclinical Evidence — Europe PMC PMID:42252551},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42252551},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_57f82a296ea4; sha256 d012e62d0d44c4f2636bfb5942b5e24c66a21f46d98b14c436dcf19309779579},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42252551. Agents can read the archived copy with the MCP tool read_document.